文献速递血栓与止血

D-二聚体作为独立试验排除深静脉血栓与其他策略相比的安全性

Safety of D-dimer testing as a stand-alone test for the exclusion of deep vein thrombosis as compared with other strategies.
PubMed 文献 · J Thromb Haemost · 2018-11-20

在挪威Østfold医院急诊连续纳入913例疑似深静脉血栓门诊患者,评估D-二聚体独立试验排除DVT的安全性。298例(33%)D-二聚体阴性,失败率0.3%(95%CI 0.1-1.9%);加用改良Wells评分失败率0.0%(95%CI 0.0-1.8%)但需多87次CUS;年龄调整D-二聚体独立试验减少80次CUS但失败率1.6%(95%CI 0.7-3.4%)。

要点

  • D-二聚体独立试验阴性可安全排除门诊患者DVT,失败率0.3%(95%CI 0.1-1.9%)。
  • 联合改良Wells评分失败率0.0%(95%CI 0.0-1.8%),但需多87次CUS检查。
  • 年龄调整D-二聚体独立试验减少80次CUS,但失败率1.6%(95%CI 0.7-3.4%),需进一步评估。

核心结论

  • 高敏D-二聚体阴性作为独立试验可安全排除门诊人群DVT,且比联合Wells评分所需CUS更少。
  • 年龄调整D-二聚体作为独立试验的安全性需在前瞻性结局研究中进一步评估。

研究设计与样本

  • 连续纳入转诊至挪威Østfold医院急诊的疑似DVT门诊患者,共913例。
  • 所有患者检测STA-Liatest D-Di PLUS D-二聚体,≥0.5 μg mL-1者转诊行压迫超声(CUS),<0.5 μg mL-1者不做进一步检查并停用抗凝。
  • 随访3个月观察静脉血栓栓塞症(VTE)。

主要发现

  • 913例中298例(33%)D-二聚体阴性,173例(18.9%)基线诊断为DVT。
  • 298例D-二聚体阴性者中1例发生DVT,失败率0.3%(95%CI 0.1-1.9%)。
  • 加用改良Wells评分失败率0.0%(95%CI 0.0-1.8%),但需多87次CUS检查。
  • 年龄调整D-二聚体独立试验比固定D-二聚体独立试验减少80次CUS,但失败率1.6%(95%CI 0.7-3.4%)。

关键数值与推荐

  • D-二聚体阈值≥0.5 μg mL-1转诊行CUS,<0.5 μg mL-1不做进一步检查并停用抗凝。
  • D-二聚体独立试验失败率0.3%(95%CI 0.1-1.9%)。
  • 联合改良Wells评分失败率0.0%(95%CI 0.0-1.8%),需多87次CUS。
  • 年龄调整D-二聚体独立试验失败率1.6%(95%CI 0.7-3.4%),减少80次CUS。

临床怎么用

  • 作者认为高敏D-二聚体阴性作为独立试验可安全排除门诊患者DVT,且所需CUS少于联合Wells评分策略。
  • 作者指出年龄调整D-二聚体作为独立试验的安全性需在前瞻性结局研究中进一步评估。

局限性

  • 年龄调整D-二聚体作为独立试验的安全性需进一步研究。
  • 年龄调整D-二聚体作为独立试验的安全性需在前瞻性结局研究中进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Essentials The aim of deep vein thrombosis (DVT) diagnostic work-up is to maximize both safety and efficiency. We explored whether D-dimer is safe and efficient as a stand-alone test to exclude DVT. Our findings suggest it is a safe, efficient and simplified diagnostic strategy. The safety of age-adjusted D-dimer as a stand-alone test requires further investigation. SUMMARY: Background Several strategies for safely excluding deep vein thrombosis (DVT) while limiting the number of imaging tests have been explored. Objectives To determine whether D-dimer testing could safely and efficiently exclude DVT as a stand-alone test, and evaluate its performance as compared with strategies that incorporate the Wells score and age-adjusted D-dimer. Patients/Methods We included consecutive outpatients referred with suspected DVT to the Emergency Department at Østfold Hospital, Norway. STA-Liatest D-Di PLUS D-dimer was analyzed for all patients. Patients with a D-dimer level of ≥ 0.5 μg mL-1 were referred for compression ultrasonography (CUS). In patients with a D-dimer level of < 0.5 μg mL-1 , no further testing was performed and anticoagulation was withheld. Patients were followed for 3 months for venous thromboembolism (VTE). Results Of the 913 included patients, 298 (33%) had a negative D-dimer result. One hundred and seventy-three patients (18.9%) were diagnosed with DVT at baseline. One of 298 patients had DVT despite having a negative D-dimer result, resulting in a failure rate of 0.3% (95% confidence interval [CI] 0.1-1.9%). Adding the modified Wells score would have yielded a failure rate of 0.0% (95% CI 0.0-1.8%) while necessitating 87 more CUS examinations. Age-adjusted D-dimer as a stand-alone test would have necessitated 80 fewer CUS examinations than fixed D-dimer as a stand-alone test, at the cost of a failure rate of 1.6% (95% CI 0.7-3.4%). Conclusions This outcome study shows that a negative high-sensitivity D-dimer result safely excludes DVT in an outpatient population, and necessitates fewer CUS than if used in combination with Wells score. The safety of stand-alone age-adjusted D-dimer needs further assessment in prospective outcome studies.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Fronas SG, Wik HS, Dahm AEA, et al. Safety of D-dimer testing as a stand-alone test for the exclusion of deep vein thrombosis as compared with other strategies. J Thromb Haemost. 2018. PMID: 30303610. doi:10.1111/jth.14314

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。